August 12, 2020
Mid-Atlantic Virtual Symposium

On demand video coming soon!

Registrants Only!

Did You Miss It?

We’re sorry you missed the live-streamed event, but the content/presentations are available for on-demand playback. Simply register and you’ll be granted access!

8/12/2020 Symposium Agenda

BioFire® Respiratory 2.1 Panel*: The Role of Syndromic Respiratory Testing in the Era of COVID-19*

Christine Ginocchio, PhD MT(ASCP)

Vice President, Global Medical Affairs, bioMérieux
Vice President, Scientific and Medical Affairs, BioFire Diagnostics

Performance of the BioFire® FilmArray® Pneumonia Panel and Considerations for Implementation

Caitlin N. Murphy, PhD D(ABMM)

Scientific Director, Microbiology, Health Network Laboratories

*This test has not been FDA cleared or approved; This test has been authorized by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Continuing Education Opportunity

2 P.A.C.E.® credits available to attendees.

BioFire Diagnostics is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. P.A.C.E.® is a registered trademark of the American Society for Clinical Laboratory Science.​